Genentech, Inc. is recalling 3,192 bottles of Klonopin (clonazepam) 0.5 mg tablets because the outer carton is missing the required 'CIV' indicator, which identifies it as a Schedule IV controlled substance. While the label on the actual bottle inside is correct, the outer packaging does not properly reflect the medication's controlled status. This recall affects 100-count bottles of the 0.5 mg strength that were distributed nationwide.
The omission of the Schedule IV (CIV) designation on the outer carton may lead to a lack of awareness regarding the medication's potential for abuse or misuse, though the primary bottle label remains accurate.
Contact healthcare provider or pharmacist for guidance and return to pharmacy for refund.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.